SEC Form 13F
| Report period | 2026-06-30 |
|---|---|
| Publicly available | 2026-08-15 |
| Reported value | $934,715,611 |
| Positions | 31 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| REVOLUTION MEDICINES INC | RVMD | COM | $77,778,695 | 415,307 |
| ABIVAX SA | ABVX | SPONSORED ADS | $65,282,608 | 489,889 |
| AXSOME THERAPEUTICS INC. | AXSM | COM | $53,461,440 | 218,415 |
| ENLIVEN THERAPEUTICS INC | ELVN | COM | $48,433,770 | 954,360 |
| BRIDGEBIO PHARMA INC | BBIO | COM | $47,172,951 | 633,364 |
| ROIVANT SCIENCES LTD | ROIV | SHS | $47,106,426 | 1,331,066 |
| UNITED THERAPEUTICS CORP DEL | UTHR | COM | $46,018,706 | 84,932 |
| CYTOKINETICS INC | CYTK | COM NEW | $44,930,228 | 527,412 |
| XENON PHARMACEUTICALS INC | XENE | COM | $36,228,072 | 600,200 |
| CELCUITY INC | CELC | COM | $34,430,547 | 329,101 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.